NYSE · CIK 0000320335
GL GLOBE LIFE INC.
Insider trading from SEC Form 4. Last filing 19 d ago. Close $164.17 on Oct 9, 2026, +27% from the 52-week low and -12% from the high.
Last 90 days
Net insider value
-$1.7M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$1.7M by 1 insider
Insiders on file
15
with a Form 4 at this company
Price and insider trades, last year
GLOct 9, 2026 · close 164.17
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at GLOBE LIFE INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Robert Edward Hensley EVP & Chief Investment Officer sell | $1.7M 10,000 shares | -45% | - | |
| 36Weak | Frank M Svoboda Co-Chairman & CEO sell | $734k 6,051 shares | -16% | +19% from low-9% from high | |
| 44Moderate | Frank M Svoboda Co-Chairman & CEO sell | $737k 6,019 shares | -16% | +21% from low-8% from high | |
| 43Moderate | Rebecca E Zorn EVP & Chief Talent Officer sell | $1.2M 10,000 shares | -42% | +20% from low-9% from high | |
| 25Weak | Michael Shane Henrie SVP & Chief Accounting Officer sell | $348k 2,750 shares | -47% | - | |
| 32Weak | Robert Edward Hensley EVP & Chief Investment Officer sell | $201k 1,610 shares | -14% | - | |
| 70Notable | Frank M Svoboda Co-Chairman & CEO sell | $2.7M 21,750 shares | -73% | - | |
| 60Notable | James Matthew Darden Co-Chairman & CEO sell | $3.0M 24,890 shares | -39% | - | |
| 60Notable | Frank M Svoboda Co-Chairman & CEO sell | $1.3M 11,000 shares | -37% | - | |
| 60Notable | Robert Brian Mitchell EVP, General Counsel and CRO sell | $3.7M 30,000 shares | -92% | - | |
| 60Notable | Michael Shane Henrie SVP & Chief Accounting Officer sell | $1.3M 10,650 shares | -85% | - | |
| 55Moderate | Mark A Blinn director sell | $340k 3,000 shares | -37% | - | |
| 50Moderate | Jennifer Allison Haworth EVP & Chief Marketing Officer sell | $1.0M 9,000 shares | -40% | - | |
| 36Weak | Michael Shane Henrie SVP & Chief Accounting Officer sell | $168k 1,500 shares | -45% | - | |
| 60Notable | Frank M Svoboda Co-Chairman & CEO sell | $1.5M 13,448 shares | -42% | - | |
| 43Moderate | Robert Brian Mitchell EVP, General Counsel and CRO sell | $879k 8,000 shares | -76% | - | |
| 45Moderate | Frank M Svoboda Co-Chairman & CEO sell | $1.6M 14,340 shares | -47% | - | |
| 43Moderate | Robert Brian Mitchell EVP, General Counsel and CRO sell | $879k 8,000 shares | -76% | - |
Congressional trades
3 trades in GL disclosed by members of Congress under the STOCK Act. All congressional trades.
- Lisa C. McClainHouse · R-MI · last Aug 13, 20251 bought
1 sold - Alan ArmstrongSenate · R-OK · last Jul 21, 20261 bought
0 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Alan Armstrong Senate · R-OK | Purchase | GL Globe Life Inc. Common Stock | $1,001 to $15k | Mar 27 / Jul 21 116 days after the trade | eFD |
Lisa C. McClain House · R-MI | Sale | GL Globe Life Inc. Common Stock | $1,001 to $15k | Jul 10, 2025 / Aug 13, 2025 34 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Purchase | GL Globe Life Inc. Common Stock | $1,001 to $15k | Jun 17, 2025 / Aug 13, 2025 57 days after the trade | Clerk |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | Robert Edward Hensley EVP & Chief Investment Officer | MOption exercise Common Stock | +10,000 | $103.23 | $1.0M | 22,384 | 19 d ago |
| Sep 22, 2026 | Robert Edward Hensley EVP & Chief Investment Officer | SOpen-market sale Common Stock | -3,344 | $169.53 | $567k | 19,040 | 19 d ago |
| Sep 22, 2026 | Robert Edward Hensley EVP & Chief Investment Officer | SOpen-market sale Common Stock | -6,656 | $170.34 | $1.1M | 12,384 | 19 d ago |
| Sep 22, 2026 | Robert Edward Hensley EVP & Chief Investment Officer | MOption exercise Employee Stock Option (Right to Buy)derivative | -10,000 | $0.00 | $0 | 23,000 | 19 d ago |
| Jun 16, 2025 | Frank M Svoboda Co-Chairman & CEO | GGift Common Stockindirect: Family Trust | -5,000 | $0.00 | $0 | 139,898 | Jun 18, 2025 |
| Jun 16, 2025 | Frank M Svoboda Co-Chairman & CEO | GGift Common Stockindirect: Family Trust | -5,000 | $0.00 | $0 | 134,898 | Jun 18, 2025 |
| Jun 4, 2025 | Frank M Svoboda Co-Chairman & CEO | MOption exercise Common Stock | +7,500 | $82.56 | $619k | 38,798 | Jun 6, 2025 |
| Jun 4, 2025 | Frank M Svoboda Co-Chairman & CEO | SOpen-market sale Common Stock | -5,551 | $121.19 | $673k | 33,247 | Jun 6, 2025 |
| Jun 4, 2025 | Frank M Svoboda Co-Chairman & CEO | SOpen-market sale Common Stock | -500 | $121.75 | $61k | 32,747 | Jun 6, 2025 |
| Jun 4, 2025 | Frank M Svoboda Co-Chairman & CEO | MOption exercise Employee Stock Option (Right to Buy)derivative | -7,500 | $0.00 | $0 | 50,000 | Jun 6, 2025 |
| May 20, 2025 | Frank M Svoboda Co-Chairman & CEO | MOption exercise Common Stock | +7,500 | $82.56 | $619k | 37,317 | May 21, 2025 |
| May 20, 2025 | Frank M Svoboda Co-Chairman & CEO | SOpen-market sale Common Stock | -6,019 | $122.51 | $737k | 31,298 | May 21, 2025 |
| May 20, 2025 | Frank M Svoboda Co-Chairman & CEO | MOption exercise Employee Stock Option (Right to Buy)derivative | -7,500 | $0.00 | $0 | 57,500 | May 21, 2025 |
| May 12, 2025 | Rebecca E Zorn EVP & Chief Talent Officer | MOption exercise Common Stock | +10,000 | $100.74 | $1.0M | 23,649 | May 13, 2025 |
| Jan 2, 2019 | Linda Addison director | AGrant or award Common Stock | +3,078 | $0.00 | $0 | 5,542 | May 13, 2025 |
| May 12, 2025 | Rebecca E Zorn EVP & Chief Talent Officer | SOpen-market sale Common Stock | -7,252 | $120.84 | $876k | 16,397 | May 13, 2025 |
| May 12, 2025 | Rebecca E Zorn EVP & Chief Talent Officer | SOpen-market sale Common Stock | -2,648 | $121.71 | $322k | 13,749 | May 13, 2025 |
| May 12, 2025 | Rebecca E Zorn EVP & Chief Talent Officer | SOpen-market sale Common Stock | -100 | $122.55 | $12k | 13,649 | May 13, 2025 |
| May 12, 2025 | Rebecca E Zorn EVP & Chief Talent Officer | MOption exercise Employee Stock Option (Right to Buy)derivative | -10,000 | $0.00 | $0 | 15,000 | May 13, 2025 |
| Mar 19, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | MOption exercise Common Stock | +2,750 | $103.23 | $284k | 5,790 | Mar 20, 2025 |
| Mar 19, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | SOpen-market sale Common Stock | -2,750 | $126.41 | $348k | 3,040 | Mar 20, 2025 |
| Mar 19, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | MOption exercise Employee Stock Option (Right to Buy)derivative | -2,750 | $0.00 | $0 | 3,250 | Mar 20, 2025 |
| Mar 3, 2025 | Philip M Jacobs director | AGrant or award Common Stock | +1,183 | $0.00 | $0 | 1,183 | Mar 5, 2025 |
| Mar 3, 2025 | Matthew J Adams director | AGrant or award Common Stock | +1,183 | $0.00 | $0 | 1,183 | Mar 5, 2025 |
| Mar 4, 2025 | Robert Edward Hensley EVP & Chief Investment Officer | SOpen-market sale Common Stock | -1,610 | $124.82 | $201k | 10,193 | Mar 5, 2025 |
| Feb 28, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | AGrant or award Common Stock | +1,220 | $0.00 | $0 | 3,040 | Mar 3, 2025 |
| Feb 28, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +3,800 | $0.00 | $0 | 3,800 | Mar 3, 2025 |
| Feb 26, 2025 | Thomas Peter Kalmbach EVP & CFO | AGrant or award Common Stock | +7,537 | $0.00 | $0 | 25,821 | Feb 28, 2025 |
| Feb 28, 2025 | Christopher Kyle Tyler EVP and Chief Info Officer | AGrant or award Common Stock | +1,125 | $0.00 | $0 | 5,245 | Feb 28, 2025 |
| Feb 28, 2025 | Dolores L Skarjune EVP and Chief Admin. Officer | AGrant or award Common Stock | +1,205 | $0.00 | $0 | 8,191 | Feb 28, 2025 |
| Feb 26, 2025 | Jennifer Allison Haworth EVP & Chief Marketing Officer | AGrant or award Common Stock | +4,846 | $0.00 | $0 | 18,331 | Feb 28, 2025 |
| Feb 26, 2025 | James Matthew Darden Co-Chairman & CEO | AGrant or award Common Stock | +11,845 | $0.00 | $0 | 50,818 | Feb 28, 2025 |
| Feb 26, 2025 | Robert Edward Hensley EVP & Chief Investment Officer | AGrant or award Common Stock | +5,384 | $0.00 | $0 | 12,674 | Feb 28, 2025 |
| Feb 26, 2025 | Michael Clay Majors EVP - Chief Strategy Officer | AGrant or award Common Stock | +7,537 | $0.00 | $0 | 48,688 | Feb 28, 2025 |
| Feb 26, 2025 | Frank M Svoboda Co-Chairman & CEO | AGrant or award Common Stock | +11,845 | $0.00 | $0 | 30,793 | Feb 28, 2025 |
| Feb 26, 2025 | Robert Brian Mitchell EVP, General Counsel and CRO | AGrant or award Common Stock | +6,999 | $0.00 | $0 | 9,519 | Feb 28, 2025 |
| Feb 26, 2025 | Rebecca E Zorn EVP & Chief Talent Officer | AGrant or award Common Stock | +4,307 | $0.00 | $0 | 14,415 | Feb 28, 2025 |
| Feb 26, 2025 | James Matthew Darden Co-Chairman & CEO | FTax withholding Common Stock | -4,662 | $121.93 | $568k | 46,156 | Feb 28, 2025 |
| Feb 26, 2025 | Thomas Peter Kalmbach EVP & CFO | FTax withholding Common Stock | -3,004 | $121.93 | $366k | 22,817 | Feb 28, 2025 |
| Feb 26, 2025 | Jennifer Allison Haworth EVP & Chief Marketing Officer | FTax withholding Common Stock | -1,907 | $121.93 | $233k | 16,424 | Feb 28, 2025 |
| Feb 26, 2025 | Robert Edward Hensley EVP & Chief Investment Officer | FTax withholding Common Stock | -2,161 | $121.93 | $263k | 10,513 | Feb 28, 2025 |
| Feb 26, 2025 | Michael Clay Majors EVP - Chief Strategy Officer | FTax withholding Common Stock | -3,007 | $121.93 | $367k | 45,681 | Feb 28, 2025 |
| Feb 26, 2025 | Robert Brian Mitchell EVP, General Counsel and CRO | FTax withholding Common Stock | -2,755 | $121.93 | $336k | 6,764 | Feb 28, 2025 |
| Feb 26, 2025 | Frank M Svoboda Co-Chairman & CEO | FTax withholding Common Stock | -4,662 | $121.93 | $568k | 26,131 | Feb 28, 2025 |
| Feb 26, 2025 | Rebecca E Zorn EVP & Chief Talent Officer | FTax withholding Common Stock | -1,746 | $121.93 | $213k | 12,669 | Feb 28, 2025 |
| Feb 28, 2025 | Michael Clay Majors EVP - Chief Strategy Officer | AGrant or award Common Stock | +1,385 | $0.00 | $0 | 47,066 | Feb 28, 2025 |
| Feb 28, 2025 | Robert Brian Mitchell EVP, General Counsel and CRO | AGrant or award Common Stock | +1,310 | $0.00 | $0 | 8,074 | Feb 28, 2025 |
| Feb 28, 2025 | Frank M Svoboda Co-Chairman & CEO | AGrant or award Common Stock | +3,686 | $0.00 | $0 | 29,817 | Feb 28, 2025 |
| Feb 28, 2025 | Christopher Kyle Tyler EVP and Chief Info Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +10,600 | $0.00 | $0 | 10,600 | Feb 28, 2025 |
| Feb 28, 2025 | Dolores L Skarjune EVP and Chief Admin. Officer | AGrant or award Employee Stock Option (right to buy)derivative | +11,200 | $0.00 | $0 | 11,200 | Feb 28, 2025 |
| Feb 28, 2025 | Rebecca E Zorn EVP & Chief Talent Officer | AGrant or award Common Stock | +980 | $0.00 | $0 | 13,649 | Feb 28, 2025 |
| Feb 28, 2024 | Thomas Peter Kalmbach EVP & CFO | AGrant or award Common Stock | +1,780 | $0.00 | $0 | 24,597 | Feb 28, 2025 |
| Feb 28, 2025 | James Matthew Darden Co-Chairman & CEO | AGrant or award Common Stock | +3,686 | $0.00 | $0 | 49,842 | Feb 28, 2025 |
| Feb 28, 2025 | Jennifer Allison Haworth EVP & Chief Marketing Officer | AGrant or award Common Stock | +1,055 | $0.00 | $0 | 17,479 | Feb 28, 2025 |
| Feb 28, 2025 | Robert Edward Hensley EVP & Chief Investment Officer | AGrant or award Common Stock | +1,290 | $0.00 | $0 | 11,803 | Feb 28, 2025 |
| Feb 28, 2025 | Michael Clay Majors EVP - Chief Strategy Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +12,800 | $0.00 | $0 | 12,800 | Feb 28, 2025 |
| Feb 28, 2025 | Rebecca E Zorn EVP & Chief Talent Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +8,600 | $0.00 | $0 | 8,600 | Feb 28, 2025 |
| Feb 28, 2025 | James Matthew Darden Co-Chairman & CEO | AGrant or award Employee Stock Option (Right to Buy)derivative | +50,471 | $0.00 | $0 | 50,471 | Feb 28, 2025 |
| Feb 28, 2025 | Thomas Peter Kalmbach EVP & CFO | AGrant or award Employee Stock Option (Right to Buy)derivative | +16,700 | $0.00 | $0 | 16,700 | Feb 28, 2025 |
| Feb 28, 2025 | Jennifer Allison Haworth EVP & Chief Marketing Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +9,300 | $0.00 | $0 | 9 | Feb 28, 2025 |
| Feb 28, 2025 | Robert Edward Hensley EVP & Chief Investment Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +12,400 | $0.00 | $0 | 12,400 | Feb 28, 2025 |
| Feb 28, 2025 | Frank M Svoboda Co-Chairman & CEO | AGrant or award Employee Stock Option (Right to Buy)derivative | +50,471 | $0.00 | $0 | 50,471 | Feb 28, 2025 |
| Feb 28, 2025 | Robert Brian Mitchell EVP, General Counsel and CRO | AGrant or award Employee Stock Option (Right to Buy)derivative | +12,200 | $0.00 | $0 | 12,200 | Feb 28, 2025 |
| Feb 13, 2025 | Frank M Svoboda Co-Chairman & CEO | MOption exercise Common Stock | +11,000 | $87.60 | $964k | 29,948 | Feb 14, 2025 |
| Feb 13, 2025 | Frank M Svoboda Co-Chairman & CEO | SOpen-market sale Common Stock | -11,000 | $122.31 | $1.3M | 18,948 | Feb 14, 2025 |
| Feb 14, 2025 | Frank M Svoboda Co-Chairman & CEO | MOption exercise Common Stock | +10,750 | $87.60 | $942k | 29,698 | Feb 14, 2025 |
| Feb 14, 2025 | Frank M Svoboda Co-Chairman & CEO | SOpen-market sale Common Stock | -8,340 | $122.37 | $1.0M | 21,358 | Feb 14, 2025 |
| Feb 14, 2025 | Frank M Svoboda Co-Chairman & CEO | SOpen-market sale Common Stock | -2,410 | $123.14 | $297k | 18,948 | Feb 14, 2025 |
| Feb 13, 2025 | Frank M Svoboda Co-Chairman & CEO | MOption exercise Employee Stock Option (Right to Buy)derivative | -11,000 | $0.00 | $0 | 10,750 | Feb 14, 2025 |
| Feb 14, 2025 | Frank M Svoboda Co-Chairman & CEO | MOption exercise Employee Stock Option (Right to Buy)derivative | -10,750 | $0.00 | $0 | 0 | Feb 14, 2025 |
| Feb 11, 2025 | James Matthew Darden Co-Chairman & CEO | MOption exercise Common Stock | +24,890 | $87.60 | $2.2M | 63,863 | Feb 12, 2025 |
| Feb 11, 2025 | Frank M Svoboda Co-Chairman & CEO | MOption exercise Common Stock | +11,000 | $87.60 | $964k | 29,948 | Feb 12, 2025 |
| Feb 11, 2025 | James Matthew Darden Co-Chairman & CEO | SOpen-market sale Common Stock | -16,618 | $121.29 | $2.0M | 47,245 | Feb 12, 2025 |
| Feb 11, 2025 | Frank M Svoboda Co-Chairman & CEO | SOpen-market sale Common Stock | -8,577 | $121.27 | $1.0M | 21,371 | Feb 12, 2025 |
| Feb 11, 2025 | James Matthew Darden Co-Chairman & CEO | SOpen-market sale Common Stock | -8,272 | $121.97 | $1.0M | 38,973 | Feb 12, 2025 |
| Feb 11, 2025 | Frank M Svoboda Co-Chairman & CEO | SOpen-market sale Common Stock | -2,423 | $122.07 | $296k | 18,948 | Feb 12, 2025 |
| Feb 11, 2025 | James Matthew Darden Co-Chairman & CEO | MOption exercise Employee Stock Option (Right to Buy)derivative | -24,890 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 11, 2025 | Frank M Svoboda Co-Chairman & CEO | MOption exercise Employee Stock Option (Right to Buy)derivative | -11,000 | $0.00 | $0 | 21,750 | Feb 12, 2025 |
| Feb 7, 2025 | Robert Brian Mitchell EVP, General Counsel and CRO | MOption exercise Common Stock | +30,000 | $82.56 | $2.5M | 32,520 | Feb 10, 2025 |
| Feb 7, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | MOption exercise Common Stock | +4,650 | $98.32 | $457k | 6,470 | Feb 10, 2025 |
| Feb 7, 2025 | Robert Brian Mitchell EVP, General Counsel and CRO | SOpen-market sale Common Stock | -9,832 | $121.48 | $1.2M | 22,688 | Feb 10, 2025 |
| Feb 7, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | MOption exercise Common Stock | +6,000 | $103.23 | $619k | 12,470 | Feb 10, 2025 |
| Feb 7, 2025 | Robert Brian Mitchell EVP, General Counsel and CRO | SOpen-market sale Common Stock | -20,168 | $122.11 | $2.5M | 2,520 | Feb 10, 2025 |
| Feb 7, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | SOpen-market sale Common Stock | -5,102 | $121.75 | $621k | 7,368 | Feb 10, 2025 |
| Feb 7, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | SOpen-market sale Common Stock | -3,439 | $122.47 | $421k | 3,929 | Feb 10, 2025 |
| Feb 7, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | SOpen-market sale Common Stock | -2,109 | $123.39 | $260k | 1,820 | Feb 10, 2025 |
| Feb 7, 2025 | Robert Brian Mitchell EVP, General Counsel and CRO | MOption exercise Employee Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | Feb 10, 2025 |
| Feb 7, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | MOption exercise Employee Stock Option (Right to Buy)derivative | -4,650 | $0.00 | $0 | 0 | Feb 10, 2025 |
| Feb 7, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | MOption exercise Employee Stock Option (Right to Buy)derivative | -6,000 | $0.00 | $0 | 6,000 | Feb 10, 2025 |
| Jan 6, 2025 | Mark A Blinn director | SOpen-market sale Common Stock | -3,000 | $113.24 | $340k | 5,122 | Jan 7, 2025 |
| Jan 6, 2025 | Jennifer Allison Haworth EVP & Chief Marketing Officer | MOption exercise Common Stock | +9,000 | $53.61 | $482k | 22,485 | Jan 7, 2025 |
| Jan 6, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | MOption exercise Common Stock | +1,500 | $98.32 | $147k | 3,320 | Jan 7, 2025 |
| Jan 6, 2025 | Frank M Svoboda Co-Chairman & CEO | MOption exercise Common Stock | +16,000 | $87.60 | $1.4M | 32,396 | Jan 7, 2025 |
| Jan 6, 2025 | Jennifer Allison Haworth EVP & Chief Marketing Officer | SOpen-market sale Common Stock | -4,591 | $112.53 | $517k | 17,894 | Jan 7, 2025 |
| Jan 6, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | SOpen-market sale Common Stock | -1,500 | $112.32 | $168k | 1,820 | Jan 7, 2025 |
| Jan 6, 2025 | Frank M Svoboda Co-Chairman & CEO | SOpen-market sale Common Stock | -9,008 | $112.30 | $1.0M | 23,388 | Jan 7, 2025 |
| Jan 6, 2025 | Jennifer Allison Haworth EVP & Chief Marketing Officer | SOpen-market sale Common Stock | -4,409 | $113.30 | $500k | 13,485 | Jan 7, 2025 |
| Jan 6, 2025 | Frank M Svoboda Co-Chairman & CEO | SOpen-market sale Common Stock | -4,440 | $113.09 | $502k | 18,948 | Jan 7, 2025 |
| Jan 6, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | MOption exercise Employee Stock Option (Right to Buy)derivative | -1,500 | $0.00 | $0 | 4,650 | Jan 7, 2025 |
| Jan 6, 2025 | Jennifer Allison Haworth EVP & Chief Marketing Officer | MOption exercise Employee Stock Option (Right to Buy)derivative | -9,000 | $0.00 | $0 | 9,000 | Jan 7, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Matthew J Adamsdirector
- Linda Addisondirector
- Mark A Blinndirector
- James Matthew DardenCo-Chairman & CEO
- Michael Shane HenrieSVP & Chief Accounting Officer
- Jennifer Allison HaworthEVP & Chief Marketing Officer
- Robert Edward HensleyEVP & Chief Investment Officer
- Philip M Jacobsdirector
- Thomas Peter KalmbachEVP & CFO
- Michael Clay MajorsEVP - Chief Strategy Officer
- Robert Brian MitchellEVP, General Counsel and CRO
- Frank M SvobodaCo-Chairman & CEO
- Dolores L SkarjuneEVP and Chief Admin. Officer
- Christopher Kyle TylerEVP and Chief Info Officer
- Rebecca E ZornEVP & Chief Talent Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.